LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

Search

Edwards Lifesciences Corp

Suletud

SektorTervishoid

77.92 1.55

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

76.74

Max

78.25

Põhinäitajad

By Trading Economics

Sissetulek

-28M

358M

Müük

27M

1.4B

P/E

Sektori keskmine

30.909

56.602

Aktsiakasum

0.64

Kasumimarginaal

25.342

Töötajad

15,800

EBITDA

-50M

434M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+5.39% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

23. juuli 2025

Turustatistika

By TradingEconomics

Turukapital

-882M

44B

Eelmine avamishind

76.37

Eelmine sulgemishind

77.92

Uudiste sentiment

By Acuity

57%

43%

324 / 382 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bearish Evidence

Edwards Lifesciences Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

15. juuli 2024, 13:57 UTC

Omandamised, ülevõtmised, äriostud

Edwards Lifesciences to Buy Innovalve for $300 Million

25. okt 2024, 09:10 UTC

Tulu

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

25. okt 2024, 08:35 UTC

Tulu

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

3. sept 2024, 20:38 UTC

Omandamised, ülevõtmised, äriostud

Edwards Lifesciences: After Recent Accelerated Repurchase Agreement and August Buybacks Via 10b5-1 Agreement and Open Market Repurchases, Company Has $1.4B in Remaining Authorization

3. sept 2024, 20:37 UTC

Omandamised, ülevõtmised, äriostud

Edwards Lifesciences Completes Sale of Critical Care Group to Becton Dickinson for $4.2B

3. sept 2024, 20:36 UTC

Omandamised, ülevõtmised, äriostud

Edwards Lifesciences Authorizes $1.5B of Additional Share Repurchases

25. juuli 2024, 09:02 UTC

Tulu
Kuumad aktsiad

Stocks to Watch Thursday: Ford, IBM, Chipotle, American Airlines -- WSJ

25. juuli 2024, 08:40 UTC

Peamised uudised

These Stocks Are Moving the Most Today: Ford, Tesla, Alphabet, Nvidia, Super Micro, IBM, ServiceNow, Chipotle, and More -- Barrons.com

24. juuli 2024, 20:17 UTC

Tulu

Edwards Lifesciences: Expects 2024 Edwards Sales Growth of 8% to 10% >EW

24. juuli 2024, 20:15 UTC

Omandamised, ülevõtmised, äriostud

Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix

24. juuli 2024, 20:15 UTC

Tulu

Edwards Lifesciences 2Q Sales $1.39B >EW

24. juuli 2024, 20:15 UTC

Tulu

Edwards Lifesciences 2Q Net $366.3M >EW

24. juuli 2024, 20:15 UTC

Tulu

Edwards Lifesciences 2Q Adj EPS 70c >EW

24. juuli 2024, 20:15 UTC

Tulu

Edwards Lifesciences 2Q EPS 61c >EW

15. juuli 2024, 13:42 UTC

Omandamised, ülevõtmised, äriostud

Edwards Lifesciences to Buy Innovalve for $300M

15. juuli 2024, 13:01 UTC

Omandamised, ülevõtmised, äriostud

Edwards Lifesciences: SAPIEN M3 Remains on Track to Become First Approved Transfemoral TMVR System in Europe by End of 2025 >EW

15. juuli 2024, 13:01 UTC

Omandamised, ülevõtmised, äriostud

Edwards Lifesciences: Acquisition Enhances TMVR Technologies to Address Large Unmet Structural Heart Patient Needs >EW

15. juuli 2024, 13:00 UTC

Omandamised, ülevõtmised, äriostud

Edwards Lifesciences to Acquire Innovalve Bio Medical Ltd., Early-Stage Transcatheter Mitral Valve Replacement Co >EW

15. juuli 2024, 13:00 UTC

Omandamised, ülevõtmised, äriostud

Edwards Lifesciences To Acquire Innovalve >EW

4. juuni 2024, 17:26 UTC

Omandamised, ülevõtmised, äriostud

Edwards Lifesciences Deal A Clear Win For Becton Dickinson, Analysts Say -- Analysis

3. juuni 2024, 13:26 UTC

Omandamised, ülevõtmised, äriostud

Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal -- IBD

3. juuni 2024, 12:25 UTC

Peamised uudised
Omandamised, ülevõtmised, äriostud

Becton Dickinson to Acquire Edwards Lifesciences' Unit for $4.2 Billion in Cash -- Update

3. juuni 2024, 11:03 UTC

Peamised uudised
Omandamised, ülevõtmised, äriostud

Becton Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2B in Cash

3. juuni 2024, 10:40 UTC

Omandamised, ülevõtmised, äriostud

Edwards Lifesciences To Sell Its Critical Care Product Group For $4.2 Billion To Becton Dickinson -- MarketWatch

3. juuni 2024, 10:32 UTC

Omandamised, ülevõtmised, äriostud

Becton Dickinson: Acquired Business Has About 4,500 Employees >BDX EW

3. juuni 2024, 10:31 UTC

Omandamised, ülevõtmised, äriostud

Becton Dickinson: Acquired Business Generated More Than $900 Million Revenue in 2023 >BDX

3. juuni 2024, 10:31 UTC

Omandamised, ülevõtmised, äriostud

Becton Dickinson: Deal Expands Portfolio of Smart Connected Care Solutions >BDX EW

3. juuni 2024, 10:30 UTC

Omandamised, ülevõtmised, äriostud

Becton Dickinson to Buy Edwards Lifesciences Critical Care Product Group for $4.2 Billion >BDX EW

3. juuni 2024, 10:30 UTC

Omandamised, ülevõtmised, äriostud

BD To Acquire Edwards Lifesciences' Critical Care Product Group For $4.2 Billion To Expand Smart Connected Care Solutions And Become An Advanced Monitoring Technology Leader >BDX EW

Võrdlus sarnastega

Hinnamuutus

Edwards Lifesciences Corp Prognoos

Hinnasiht

By TipRanks

5.39% tõus

12 kuu keskmine prognoos

Keskmine 80.89 USD  5.39%

Kõrge 90 USD

Madal 75 USD

Põhineb 14 Wall Streeti analüütiku instrumendi Edwards Lifesciences Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

14 ratings

7

Osta

7

Hoia

0

Müü

Tehniline skoor

By Trading Central

74.52 / 75.54Toetus ja vastupanu

Lühikene perspektiiv

Weak Bearish Evidence

Keskpikk perspektiiv

Strong Bullish Evidence

Pikk perspektiiv

Strong Bullish Evidence

Sentiment

By Acuity

324 / 382 Pingereas Tervishoid

Uudiste sentiment

Tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Edwards Lifesciences Corp

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.